X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (465) 465
Publication (79) 79
Book Chapter (30) 30
Conference Proceeding (10) 10
Book Review (5) 5
Dissertation (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (291) 291
type 1 diabetes (285) 285
humans (250) 250
t1d (223) 223
endocrinology & metabolism (160) 160
diabetes (151) 151
female (147) 147
male (137) 137
child (110) 110
children (107) 107
adolescent (96) 96
pediatrics (91) 91
autoimmunity (90) 90
insulin (90) 90
diabetes mellitus, type 1 - immunology (81) 81
animals (74) 74
immunology (70) 70
mellitus (69) 69
article (61) 61
diabetes mellitus, type 1 - genetics (60) 60
adult (58) 58
mice (58) 58
analysis (55) 55
diabetes mellitus (53) 53
glucose (52) 52
adolescents (50) 50
child, preschool (50) 50
glycemic control (50) 50
diabetes mellitus, type 1 - drug therapy (49) 49
diabetes mellitus, type 1 - blood (48) 48
t1d exchange (46) 46
health aspects (45) 45
risk factors (45) 45
t cells (42) 42
autoantibodies (40) 40
risk (38) 38
young adult (37) 37
diabetes mellitus, type 1 - epidemiology (35) 35
diabetes therapy (35) 35
hypoglycemia (35) 35
diabetes mellitus, type 1 - complications (33) 33
diabetes mellitus, type 1 - therapy (31) 31
association (30) 30
disease (30) 30
medical and health sciences (30) 30
medicin och hälsovetenskap (30) 30
mice, inbred nod (30) 30
diabetes mellitus, type 1 - metabolism (29) 29
expression (28) 28
genetic aspects (28) 28
infant (28) 28
onset (28) 28
genetic predisposition to disease (27) 27
medicine (27) 27
research (27) 27
insulin - administration & dosage (26) 26
middle aged (26) 26
case-control studies (25) 25
general pediatric endocrinology, t1d, hypoglycemia, and growth (25) 25
glycosylated hemoglobin (25) 25
pediatric endocrinology (25) 25
t-cells (25) 25
type-1 (25) 25
youth (25) 25
medicine & public health (24) 24
nod mice (24) 24
glycated hemoglobin a - analysis (23) 23
insulin - therapeutic use (23) 23
dendritic cells (22) 22
endocrine system diseases (22) 22
genes (22) 22
hyperglycemia (22) 22
hypoglycemic agents - administration & dosage (22) 22
medicine, research & experimental (22) 22
body mass index (21) 21
cohort studies (21) 21
development and progression (21) 21
type 1 diabetes mellitus (21) 21
age (20) 20
alleles (20) 20
blood glucose - metabolism (20) 20
genotype (20) 20
hypoglycemic agents - therapeutic use (20) 20
prevention (20) 20
susceptibility (20) 20
abridged index medicus (19) 19
t2d (19) 19
antibodies (18) 18
complications (18) 18
dextrose (18) 18
diabetes mellitus, type 1 - diagnosis (18) 18
gene expression (18) 18
genome-wide association (18) 18
population (18) 18
regulatory t-cells (18) 18
t1d, type 1 diabetes (18) 18
teenagers (18) 18
therapy (18) 18
blood glucose - analysis (17) 17
cells (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
DIABETES CARE, ISSN 0149-5992, 09/2018, Volume 41, Issue 9, pp. 1981 - 1990
OBJECTIVEThe objective of this study was to evaluate the efficacy and safety of the dual sodium-glucose cotransporter 1 and 2 inhibitor sotagliflozin compared... 
CLINICAL ENDOCRINOLOGISTS | GLYCEMIC CONTROL | T1D EXCHANGE | EFFICACY | AMERICAN ASSOCIATION | SAFETY | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | ADJUNCT | COMPLICATIONS | INHIBITORS
Journal Article
BMC psychiatry, ISSN 1471-244X, 01/2020, Volume 20, Issue 1, pp. 5 - 7
Caring for a child with Type 1 Diabetes (T1D) pose a significant burden on parents especially when they struggle with their child's T1D management. The... 
Saudi Arabia | Children | Diabetes | Riyadh | Stress | Parents
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2018, Volume 20, Issue 8, pp. 1859 - 1867
Aims Our current understanding of the pathogenesis of type 1 diabetes (T1D) arose, in large part, from studies using the non‐obese diabetic (NOD) mouse model.... 
type 1 diabetes | inflammatory pathways | human islets | short‐duration T1D | IL23 | T1D | functional genomics | IL23/p19 | RNA‐sequencing | RNA-sequencing | short-duration T1D | POPULATION | COMBINATION THERAPY | MOUSE | MELLITUS | PANCREATIC-ISLETS | MODELS | RNA-SEQ | ENDOCRINOLOGY & METABOLISM | p19 | INSULITIS | T-CELLS | Islets of Langerhans - drug effects | Interleukin-23 Subunit p19 - antagonists & inhibitors | Diabetes Mellitus, Type 1 - prevention & control | Humans | Diabetes Mellitus, Type 1 - metabolism | Antibodies, Monoclonal - therapeutic use | Male | Gene Expression Profiling | Interleukin-23 Subunit p19 - metabolism | Islets of Langerhans - metabolism | Interleukin-23 Subunit p19 - genetics | Adult | Female | Diabetes Mellitus, Type 1 - immunology | Child | Islets of Langerhans - pathology | Diabetes Mellitus, Type 1 - physiopathology | Gene Expression Regulation | Islets of Langerhans - immunology | Immunity, Innate | Disease Progression | Proof of Concept Study | Disease-Free Survival | Animals | Mice, Inbred NOD | Tissue Donors | Cadaver | Cluster Analysis | Genetic research | Gene expression | Type 1 diabetes | Genes | Analysis | Translation | Genomic analysis | Therapeutic applications | Diabetes mellitus | Data processing | Innate immunity | Diabetes mellitus (insulin dependent) | Inflammation | Ribonucleic acid--RNA | Rodents | Monoclonal antibodies | Diabetes | Pancreas
Journal Article
Diabetes Technology & Therapeutics, ISSN 1520-9156, 02/2019, Volume 21, Issue 2, pp. 66 - 72
Objective: To provide a snapshot of the profile of adults and youth with type 1 diabetes (T1D) in the United States and assessment of longitudinal changes in... 
Original Articles | Continuous glucose monitor use | T1D Exchange registry | Insulin pump use | GLYCEMIC CONTROL | SEVERE HYPOGLYCEMIA | ADULTS | KETOACIDOSIS | CHILDREN | AUSTRIA | RATES | ADOLESCENTS | ENDOCRINOLOGY & METABOLISM | YOUTH | CROSS-SECTIONAL ANALYSIS
Journal Article
DIABETES CARE, ISSN 0149-5992, 01/2018, Volume 41, Issue 1, pp. S126 - S136
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to... 
GLUTEN-FREE DIET | EXCHANGE CLINIC REGISTRY | GLYCEMIC CONTROL | AMERICAN-DIABETES-ASSOCIATION | T1D EXCHANGE | RISK-FACTORS | POSITION STATEMENT | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | QUALITY-OF-LIFE | CELIAC-DISEASE | Care and treatment | Hyperglycemia | Diabetes | Diagnosis | Risk factors
Journal Article
Clinical Immunology, ISSN 1521-6616, 2013, Volume 148, Issue 1, pp. 4 - 15
Abstract Type 1 diabetes (T1D) patients have numeral and functional defects in peripheral immune cells, but the pre-diabetic period is fairly uncharacterized.... 
Allergy and Immunology | T1D autoantibodies | T1D high risk | Gene expression | Type 1 diabetes | PBMC | PCR array | AUTOANTIBODIES | POINT MUTATION | GLUTAMIC-ACID DECARBOXYLASE | ALPHA | MELLITUS | IMMUNOLOGY | INSULIN | AUTOIMMUNITY | COSTIMULATORY PATHWAYS | REGULATORY T-CELLS | DISEASE PROGRESSION | C-Peptide - blood | Humans | Tumor Necrosis Factor-alpha - blood | Tumor Necrosis Factor-alpha - genetics | Male | Gene Expression Profiling | Leukocyte Common Antigens - immunology | Sweden | Leukocytes, Mononuclear - immunology | Peptide Fragments - immunology | Peptide Fragments - blood | Prediabetic State - immunology | Tumor Necrosis Factor-alpha - immunology | Female | Diabetes Mellitus, Type 1 - immunology | Child | Peptide Fragments - genetics | Prediabetic State - blood | RNA, Messenger - genetics | HLA Antigens - immunology | Reverse Transcriptase Polymerase Chain Reaction | HLA Antigens - blood | Diabetes Mellitus, Type 1 - blood | Adolescent | Leukocyte Common Antigens - genetics | RNA, Messenger - chemistry | C-Peptide - immunology | Leukocyte Common Antigens - blood | C-Peptide - genetics | Cohort Studies | Autoimmunity | Peptides | Tumor necrosis factor | Children | Health aspects | Risk factors | Type 1 diabetes; Gene expression; PBMC; T1D high risk; T1D autoantibodies; PCR array | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Metabolism, ISSN 0026-0495, 11/2019, Volume 100, p. 153952
Diabetes mellitus (DM) is a heterogeneous group of disorders characterized by persistent hyperglycemia. Its two most common forms are type 1 diabetes (T1D) and... 
Epigenetics | MODY | Diabetes | Gene–environment interactions (G × E) | T1D | T2D
Journal Article
Chinese Journal of Microbiology and Immunology (China), ISSN 0254-5101, 05/2018, Volume 38, Issue 5, pp. 327 - 336
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 24, pp. 2337 - 2348
Journal Article
Pediatrie pro Praxi, ISSN 1213-0494, 2018, Volume 19, Issue 4, pp. 232 - 234
Journal Article
Journal of Consumer Health on the Internet, ISSN 1539-8285, 10/2019, Volume 23, Issue 4, pp. 411 - 418
Type 1 diabetes (T1D) diagnoses are steadily rising, so support for families, caregivers, and those diagnosed with T1D is equally on the rise. This specific... 
children | T1D | Childhood | diabetes | type I diabetes | children with diabetes
Journal Article
Journal of Proteome Research, ISSN 1535-3893, 03/2019, Volume 18, Issue 3, pp. 814 - 825
We recently discovered hybrid insulin peptides (HIPs) as a novel class of post-translationally modified peptides in murine-derived beta cell tumors, and we... 
Hybrid insulin peptide (HIP) | Pancreatic islets | Beta cell proteome | Mass spectrometry | Type 1 diabetes (T1D) | CD4 T-CELLS | DATABASE | BIOCHEMICAL RESEARCH METHODS | beta cell proteome | hybrid insulin peptide (HIP) | mass spectrometry | POSTTRANSLATIONAL MODIFICATIONS | pancreatic islets | type 1 diabetes (T1D) | ANTIGEN
Journal Article
DIABETES CARE, ISSN 0149-5992, 12/2018, Volume 41, Issue 12, pp. 2560 - 2569
OBJECTIVE To evaluate the safety and efficacy of empagliflozin 10- and 25-mg doses plus a unique lower dose (2.5 mg) as adjunct to intensified insulin in... 
COMPLICATIONS TRIAL/EPIDEMIOLOGY | EXCHANGE CLINIC REGISTRY | GLYCEMIC CONTROL | INTERVENTIONS | T1D EXCHANGE | EFFICACY | SAFETY | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | RANDOMIZED-TRIAL | COTRANSPORTER 2 INHIBITION | Treatment outcome | Usage | Drug therapy | Type 1 diabetes | Insulin | Analysis
Journal Article